UNLABELLED: Among 50,461 postmenopausal women, 1,822 fractures occurred (57% minor non-hip, non-vertebral [NHNV], 26% major NHNV, 10% spine, 7% hip) over 1 year. Spine fractures had the greatest detrimental effect on EQ-5D, followed by major NHNV and hip fractures. Decreases in physical function and health status were greatest for spine or hip fractures. INTRODUCTION: There is growing evidence that NHNV fractures result in substantial morbidity and healthcare costs. The aim of this prospective study was to assess the effect of these NHNV fractures on quality of life. METHODS: We analyzed the 1-year incidences of hip, spine, major NHNV (pelvis/leg, shoulder/arm) and minor NHNV (wrist/hand, ankle/foot, rib/clavicle) fractures among women from the Global Longitudinal study of Osteoporosis in Women (GLOW). Health-related quality of life (HRQL) was analyzed using the EuroQol EQ-5D tool and the SF-36 health survey. RESULTS: Among 50,461 women analyzed, there were 1,822 fractures (57% minor NHNV, 26% major NHNV, 10% spine, 7% hip) over 1 year. Spine fractures had the greatest detrimental effect on EQ-5D summary scores, followed by major NHNV and hip fractures. The number of women with mobility problems increased most for those with major NHNV and spine fractures (both +8%); spine fractures were associated with the largest increases in problems with self care (+11%), activities (+14%), and pain/discomfort (+12%). Decreases in physical function and health status were greatest for those with spine or hip fractures. Multivariable modeling found that EQ-5D reduction was greatest for spine fractures, followed by hip and major/minor NHNV. Statistically significant reductions in SF-36 physical function were found for spine fractures, and were borderline significant for major NHNV fractures. CONCLUSION: This prospective study shows that NHNV fractures have a detrimental effect on HRQL. Efforts to optimize the care of osteoporosis patients should include the prevention of NHNV fractures.
UNLABELLED: Among 50,461 postmenopausal women, 1,822 fractures occurred (57% minor non-hip, non-vertebral [NHNV], 26% major NHNV, 10% spine, 7% hip) over 1 year. Spine fractures had the greatest detrimental effect on EQ-5D, followed by major NHNV and hip fractures. Decreases in physical function and health status were greatest for spine or hip fractures. INTRODUCTION: There is growing evidence that NHNV fractures result in substantial morbidity and healthcare costs. The aim of this prospective study was to assess the effect of these NHNV fractures on quality of life. METHODS: We analyzed the 1-year incidences of hip, spine, major NHNV (pelvis/leg, shoulder/arm) and minor NHNV (wrist/hand, ankle/foot, rib/clavicle) fractures among women from the Global Longitudinal study of Osteoporosis in Women (GLOW). Health-related quality of life (HRQL) was analyzed using the EuroQol EQ-5D tool and the SF-36 health survey. RESULTS: Among 50,461 women analyzed, there were 1,822 fractures (57% minor NHNV, 26% major NHNV, 10% spine, 7% hip) over 1 year. Spine fractures had the greatest detrimental effect on EQ-5D summary scores, followed by major NHNV and hip fractures. The number of women with mobility problems increased most for those with major NHNV and spine fractures (both +8%); spine fractures were associated with the largest increases in problems with self care (+11%), activities (+14%), and pain/discomfort (+12%). Decreases in physical function and health status were greatest for those with spine or hip fractures. Multivariable modeling found that EQ-5D reduction was greatest for spine fractures, followed by hip and major/minor NHNV. Statistically significant reductions in SF-36 physical function were found for spine fractures, and were borderline significant for major NHNV fractures. CONCLUSION: This prospective study shows that NHNV fractures have a detrimental effect on HRQL. Efforts to optimize the care of osteoporosispatients should include the prevention of NHNV fractures.
Authors: Susan K Brenneman; Elizabeth Barrett-Connor; Shiva Sajjan; Leona E Markson; Ethel S Siris Journal: J Bone Miner Res Date: 2006-06 Impact factor: 6.741
Authors: J D Adachi; G Loannidis; C Berger; L Joseph; A Papaioannou; L Pickard; E A Papadimitropoulos; W Hopman; S Poliquin; J C Prior; D A Hanley; W P Olszynski; T Anastassiades; J P Brown; T Murray; S A Jackson; A Tenenhouse Journal: Osteoporos Int Date: 2001 Impact factor: 4.507
Authors: E M Dennison; K A Jameson; H E Syddall; H J Martin; J Cushnaghan; A Aihie Sayer; C Cooper Journal: Osteoporos Int Date: 2009-12-19 Impact factor: 4.507
Authors: Jonathan D Adachi; Silvano Adami; Stephen Gehlbach; Frederick A Anderson; Steven Boonen; Roland D Chapurlat; Juliet E Compston; Cyrus Cooper; Pierre Delmas; Adolfo Díez-Pérez; Susan L Greenspan; Frederick H Hooven; Andrea Z LaCroix; Robert Lindsay; J Coen Netelenbos; Olivia Wu; Johannes Pfeilschifter; Christian Roux; Kenneth G Saag; Philip N Sambrook; Stuart Silverman; Ethel S Siris; Grigor Nika; Nelson B Watts Journal: Mayo Clin Proc Date: 2010-07-15 Impact factor: 7.616
Authors: F H Hooven; J D Adachi; S Adami; S Boonen; J Compston; C Cooper; P Delmas; A Diez-Perez; S Gehlbach; S L Greenspan; A LaCroix; R Lindsay; J C Netelenbos; J Pfeilschifter; C Roux; K G Saag; P Sambrook; S Silverman; E Siris; N B Watts; F A Anderson Journal: Osteoporos Int Date: 2009-05-26 Impact factor: 4.507
Authors: Marilina Piemontese; Maria Almeida; Alexander G Robling; Ha-Neui Kim; Jinhu Xiong; Jeff D Thostenson; Robert S Weinstein; Stavros C Manolagas; Charles A O'Brien; Robert L Jilka Journal: JCI Insight Date: 2017-09-07
Authors: D S Domiciano; L G Machado; C P Figueiredo; V F Caparbo; R M Oliveira; P R Menezes; R M R Pereira Journal: Osteoporos Int Date: 2020-10-10 Impact factor: 4.507
Authors: Carolyn J Crandall; Michael J LaMonte; Beverly M Snively; Meryl S LeBoff; Jane A Cauley; Cora E Lewis; Robert Wallace; Wenjun Li; Zhao Chen; John A Robbins; Jean Wactawski-Wende Journal: J Gerontol A Biol Sci Med Sci Date: 2016-03 Impact factor: 6.053